您当前的位置：
首页 >
文章列表页 >
A novel microRNA miR-MTCO3P38 inhibits malignant progression via STAT3/PTTG1/MYC in hepatocellular carcinoma
Short communication | 更新时间：2022-06-24

    • A novel microRNA miR-MTCO3P38 inhibits malignant progression via STAT3/PTTG1/MYC in hepatocellular carcinoma

    • A novel microRNA miR-MTCO3P38 inhibits malignant progression via STAT3/PTTG1/MYC in hepatocellular carcinoma

    • Genes & Diseases   2022年9卷第4期
    • 作者机构：

      1. Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University,Hubei,Wuhan,PR China,430071

      2. Department of Hepatobiliary and Pancreatic Surgery, The First People's Hospital of Jingmen,Hubei,Jingmen,PR China,448000

      3. Guangzhou Women and Children's Medical Center, Guangzhou Medical University,Guangdong,Guangzhou,PR China,510120

      4. Department of Hepatobiliary Surgery, Tianjin Medical University General Hospital,Tianjin,PR China,300052

    • DOI：10.1016/j.gendis.2021.11.006    

      中图分类号：

    • 纸质出版日期：2022，

      网络出版日期：2022-7-1，

    扫 描 看 全 文

  • Deliang Guo, Yang Gu, Dong Ma, 等. A novel microRNA miR-MTCO3P38 inhibits malignant progression via STAT3/PTTG1/MYC in hepatocellular carcinoma[J]. Genes & Diseases, 2022,9(4). DOI： 10.1016/j.gendis.2021.11.006.

    Deliang Guo, Yang Gu, Dong Ma, et al. A novel microRNA miR-MTCO3P38 inhibits malignant progression via STAT3/PTTG1/MYC in hepatocellular carcinoma[J]. Genes & Diseases, 2022,9(4). DOI： 10.1016/j.gendis.2021.11.006.

  •  
  •  
查看原文

0

浏览量

0

下载量

0

CSCD

文章被引用时，请邮件提醒。
提交
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

暂无数据

相关作者

暂无数据

相关机构

暂无数据
0